Thor medical - Trmed

u/Duke_Rubio · Reddit — r/ValueInvesting · September 13, 2026 at 11:29 · ⬆ 1 pts  | View on Reddit ↗
AI Summary

{"summary": "Author presents a bullish case for Thor Medical (TRMED.OL), a Norwegian Th-228/Ra-224/Pb-212 isotope supplier with commercial production, a funded US expansion, and a tax-loss shield, while acknowledging dilution and short-interest risks.", "reason": "The author provides a fundamental investment thesis for TRMED.OL, citing specific operational catalysts (plant completion, commercial production), financial catalysts (tax-loss carryforward, backlog, funding), and a clear rationale for why the current valuation is disconnected from these fundamental", "ideas": [{"symbol": "TRMED.OL", "direction": "long", "thesis": "Author argues Thor Medical is a Norwegian thorium isotope supplier whose AlphaOne plant is complete and in commercial production, with first deliveries done, self-scaling output, and a cited ~NOK 850m backlog from named radiopharma customers. The author sees revenue potential around NOK 330–350m at 21k patient-dose equivalents and positive EBITDA targeted around 2027, with a NOK 300m raise funding a US expansion called AlphaGlobal. The stock is viewed as cheap because plant risk is largely behind, cash is in, and the market gives little credit to a ~NOK 677m tax-loss carryforward from the old Nordic Nanovector shell. Main stated risks include dilution, a disclosed Two Sigma short, an ongoing subsequent offering, and the fact that drug or device approvals do not guarantee Thor wins every isotope kilo.", "thesis_short": "Thor Medical self-scaling isotope supplier, cash-funded, tax shield undervalued", "quote": "Why it can be cheap: plant risk is largely behind, cash is in, US step is funded, you are not underwriting one binary readout.", "confidence": 0.85, "sentiment": 0.7, "timeframe": "multi-year; EBITDA target around 2027, guidance 3–10 years"}], "model": "gemini-3.1-flash-lite", "failure_count": 0, "verified": true, "extraction_model": "deepseek-flash"}

Score 1
Full Post Text
Ideas
u/Duke_Rubio Reddit r/ValueInvesting
Thor Medical self-scaling isotope supplier, cash-funded, tax shield undervalued
Author argues Thor Medical is a Norwegian thorium isotope supplier whose AlphaOne plant is complete and in commercial production, with first deliveries done, self-scaling output, and a cited ~NOK 850m backlog from named radiopharma customers. The author sees revenue potential around NOK 330–350m at 21k patient-dose equivalents and positive EBITDA targeted around 2027, with a NOK 300m raise funding a US expansion called AlphaGlobal. The stock is viewed as cheap because plant risk is largely behind, cash is in, and the market gives little credit to a ~NOK 677m tax-loss carryforward from the old Nordic Nanovector shell. Main stated risks include dilution, a disclosed Two Sigma short, an ongoing subsequent offering, and the fact that drug or device approvals do not guarantee Thor wins every isotope kilo.
More from Reddit — r/ValueInvesting

This Reddit post, published September 13, 2026, features u/Duke_Rubio discussing TRMED.OL. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/Duke_Rubio  · Tickers: TRMED.OL